Patient Safety & Pharmacovigilance at Boehringer Ingelheim
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Search
Boehringer Ingelheim Office Hours
Boehringer Ingelheim Office Hours
Research Institute of Molecular Pathology IMP
Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the Research Institute of Molecular Pathology (IMP) is a leading institute for biomedical researchin Vienna, Austria.
Small Molecule Drug Discovery
Boehringer Ingelheim scientists continue to expand the horizons of what small molecule drugs can achieve.
Our innovation strategy
Our Innovation Strategy at Boehringer Ingelheim in Research and Development
How Boehringer Ingelheim is Supporting Grass Roots Innovation
Our Grass Roots activities support life-science innovators with mentoring and networking opportunities
New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
Human Health Innovation
Boehringer Ingelheim focuses its research activities on disease areas with a high unmet medical need.
Cancer cell directed therapies
At Boehringer Ingelheim, we are investigating cancer cell directed therapies that target key cancer drivers and hallmarks to directly kill cancer cells.
Making sustainable medicines through eco-design
Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Always Here – Our Commitment for Ukraine
Boehringer Ingelheim has actively supported Ukrainian civilians throughout the Russian invasion.
Patients in Focus
Boehringer Ingelheim RCV provides over six million patients with innovative therapies. Ensuring that the patients’ needs at every stage are met precisely is of decisive importance.
BA_Obavijest o zaštiti podataka za zdravstvene radnike
Croatia_Obavijest o zastiti podataka za zdravstvene radnike
Serbia_Obavestenje o zastiti podataka o licnosti za zaposlene u zdravstvu
Supply chain at Boehringer Ingelheim
The supply chain at Boehringer covers two main areas: the entire process up to the finished product, and the commercial supply chain, the delivery of products to customers.
Veterinarians: caught between excellence and exhaustion
Many children dream of becoming a veterinarian. What happens when that dream comes true?
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Grass Roots
Grass Roots
Animal Health Partnering Interests
Animal Health Partnering Interests
Privacy Notice
Privacy Notice
Parasiticides
Parasiticides
Open Innovation Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Animal Health Innovation
Animal Health Innovation
Human Health Partnering
Human Health Partnering